NCT00659191View on ClinicalTrials.gov

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
HIV Infection
Interventions
DRUG

GSK1265744

Trial Locations (5)

28209

GSK Investigational Site, Charlotte

32804

GSK Investigational Site, Orlando

33306

GSK Investigational Site, Fort Lauderdale

33316

GSK Investigational Site, Fort Lauderdale

53704

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00659191 - A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744 | Biotech Hunter | Biotech Hunter